Atlas Trials

Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

Clinical trial NCT06891872 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06891872
Sponsor
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Varicella (chickenpox)MMR VaccineDTaP Vaccine
Start date
2025-05-01
Primary completion
2025-12-01
Enrollment
720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.